T-cell therapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

T-cell therapy
Mar 18, 2025, 12:07 | Blog
Shushan Hovsepyan: My top 7 sessions to attend at the ESMO Sarcoma and Rare Tumor Annual Congress
Shushan Hovsepyan, Editor-in-Chief of OncoDaily Medical Journal, shared a post on LinkedIn: "The ESMO Sarcoma…
Mar 4, 2025, 09:01 | Blog
Charles Gaulin: Optimizing care delivery for Rural New England by Dartmouth Cancer Center
Charles Gaulin, Hematologic Oncologist at Dartmouth Hitchcock Medical Center and Clinics, shared his recent article on LinkedIn:…
Feb 25, 2025, 07:36 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Feb 24, 2025, 09:47 | Science
Patrick Hwu: How can we prevent T cell exhaustion?
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared an article by Shijun Ma,…
Feb 20, 2025, 09:27 | Science
Patrick Hwu: How can we treat solid tumor such as glioblastoma with T-cell therapy?
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post on LinkedIn about…
Jan 4, 2025, 17:23 | Science
Marit van Buuren: Our work on a personalized, autologous neoantigen-specific T cell therapy
Marit van Buuren, Senior Director of T Cell Immunology and Process Development at BioNTech SE,…
Oct 19, 2024, 13:59 | Insight
Myeloma Paper of the Day, October 19th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Case series of patients…
Oct 18, 2024, 12:58 | Blog
Rahul Banerjee: Multicenter description of immune effector cell-associated enterocolitis as a novel toxicity of CAR T-cell therapy in multiple myeloma
Rahul Banerjee shared a post on X, about recent paper published in Blood Cancer Journal:…
Aug 13, 2024, 07:26 | Blog
Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T-Cell Engagers
Medigene AG and WuXi Biologics enter into a three-year, multi-target strategic partnership to design and co-research…
Aug 13, 2024, 02:39 | Blog
MD Anderson Cancer Center and collaborators launch project to study T-cells on International Space Station
The University of Texas MD Anderson Cancer Center and collaborators are initiating a research project…
Aug 6, 2024, 11:47 | Drugs
FDA Grants Accelerated Approval to Afamitresgene Autoleucel (TECELRA) for Treating Advanced Synovial Sarcoma
On August 2, 2024, the FDA made history by granting accelerated approval to afamitresgene autoleucel…
Aug 1, 2024, 03:35 | Insight
Infection Prevention and Management after CAR T Cell Therapy for Hematological Malignancies
Mostafa Faisal, Adjunct Assistant Professor at Alfaisal University, shared a paper Zainab Shahid et al.…
Jul 1, 2024, 02:27 | Blog
Krishna Komanduri: Big deal and a win for immunotherapy patients
Krishna Komanduri, Physician in Chief at UCSF Helen Diller Family Comprehensive Cancer Center, made the following post…
Jun 11, 2024, 15:17 | Blog
Julian Ashby: Deep preclinical characterization is essential to increase the chances of success in clinical trials
Julian Ashby, Product Marketing Manager at LUMICKS, shared on LinkedIn: “Each year, companies use tens…
May 23, 2024, 07:44 | Blog
Medigene's Global Research and Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
Medigene AG an immuno-oncology platform company focusing on the discovery and development of differentiated T cell…
Apr 20, 2024, 07:47 | Drugs
Paper summary by Marco Donia
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 15, 2024, 02:21 | Societies
Congratulations Michel Sadelain for being awarded the Gairdner Foundation International Awards - AACR
American Association for Cancer Research (AACR) shared on X: “Congratulations to Michel Sadelain of Memorial…
Apr 5, 2024, 08:40 | Insight
Piotr Wysocki: Vaccination of adult cancer patients - ASCO guidelines
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Mar 17, 2024, 20:09 | Blog
Our project, DART2OS, has received the prestigious "Emerging Fields" grant by Austrian Science Fund FWF - St. Anna Children's Cancer Research Institute
Quoting St. Anna Children's Cancer Research Institute on LinkedIn: "We are excited to share that…
Feb 22, 2024, 23:27 | Blog
Amalya Sargsyan: First approved T cell therapy for solid tumors
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, shared a post by Nicholas Restifo,…
Dec 5, 2023, 12:48 | Career
Sarah's expertise will be instrumental in helping us advance our mission of bringing potentially transformational TCR-T's to patients - Neogene Therapeutics
Neogene Therapeutics announced on their LinkedIn: "Today, we are spotlighting one of our exceptional new…
Sep 19, 2023, 09:30 | Insight
Ishwaria Subbiah: Check out our study where we developed and validated a new PRO tool specifically for symptom burden after cellular therapy!
Ishwaria Subbiah, shared the following on X/Twitter: "Supportive care oncology x blood cancer collaborations are…
All: 22 Posts: 1 - 100
Special Coverage